|
| DNA Vaccines [1–42, 66] | RNA Vaccines [5, 42–55] | Future Direction: RNA and Nanomaterials [6, 53, 55–65, 67–77] |
|
Design | Relatively easy, inexpensive, and quick to construct. Easy to manipulate. Does not require cold chain. | Relatively easy, inexpensive, and quick to construct. Can be produced in large amounts in vitro from DNA template. | Functionalized nanomaterials can be conjugated to further stabilize RNA and to increase penetration. |
|
Delivery | IM injection is most common, but often requires prime/boost. Biolistic bombardment with DNA-coated gold microparticles is currently most efficient. Needle-free delivery via Bioinjector. | Currently, there is no standard delivery method; IM injection is most common. Liposome carriers can also be used. | Gene gun delivery of RNA conjugated with dendrimers and various nanoparticles as stabilizing delivery vehicles. |
|
Stability | Generally stable at room temperature. Long shelf life. | Unstable for storage unless oxidation, hydrolysis, and contact with nucleases are prevented. Quickly degraded in physiological fluid, although studies show unprotected RNA can induce immune response. | Complexing the RNA with multiple nanomaterials can have a compounding effect to increase stability for storage and delivery. |
|
Safety | Considered relatively safe, though there is theoretical risk of insertional mutagenesis after integration, induction of autoimmunity, and transfer of antibiotic resistance. | Rapidly cleared from tissue and does not need to enter nucleus; therefore, there is no risk of insertional mutagenesis after integration, induction of autoimmunity, or transfer of antibiotic resistance. | Continue researching the effect of shape, size, and surface chemistry on biocompatibility and cellular interactions of various nanomaterials. |
|
Immunogenicity | Activate both cellular and humoral pathways. Poor result in human clinical trials. Must be transported to the nucleus in order to exert biological effect. | Activate both cellular and humoral pathways. No need to cross nuclear membrane to exert its biological effect. No need to be replicated or transcribed. | Complex RNA to nanomaterials that recognize and target specific cells. Continue research on nanomaterials that penetrate the cell membrane with adverse cellular effects. |
|